Zsofia Bittner is currently the QC Drug Substance Projects Lead at Takeda, where they oversee quality control initiatives. Previously, Zsofia worked as a Principal Scientist in Infectious Diseases at Prime Vector Technologies, focusing on viral vector vaccines and preclinical immunogenicity data. They also held a position as a Senior Scientist at CureVac, contributing to non-clinical mRNA vaccine development against Influenza in collaboration with GSK. Zsofia completed their PhD in Biochemistry at the University of Tuebingen and holds a Master's degree in Molecular Medicine from Eberhard-Karls-Universität Tübingen.
This person is not in any teams
This person is not in any offices